The majority of Americans do not live in a biotech hub. Yet 62 percent of all U.S. biopharma venture investment occurs in Massachusetts and California, according to Pitchbook, while 77 percent of ...
Scientific breakthroughs will enable a future of personalized drug discovery, where precision medicine makes it possible to receive the right dose of the right medicine at the right time. America’s ...
Two years ago, Incendia Therapeutics, a biotechnology company specializing in cancer-related research, moved into Allston in a building along the Massachusetts Turnpike. Incendia, along with nearly a ...
Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...
Philadelphia is known as a thriving life sciences hub, but industry leaders are working to push it to the next level. While the region has the resources and collaboration to be a successful precision ...
A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...
Pathway Triangle signed Liquidia as first tenant in 70,000-square-foot lease. Vacancy in life sciences manufacturing hit 66.6% in Raleigh-Durham market. Developers expect absorption of 1M+ square feet ...
(TNS) — A groundbreaking $44 million federal biotechnology grant that would have benefited several Birmingham institutions has been cancelled. The Birmingham Biotechnology Hub, led by Southern ...
TheraVectys SA is weighing Hong Kong for its public market debut as biotech listings rebound and Asia’s funding role grows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results